ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon Biologics gets UK MHRA nod for biosimilars Vevzuo, Evfraxy
Biocon Biologics Ltd has achieved a significant milestone. It has secured marketing authorizations in the UK for Vevzuo and Evfraxy. These are biosimilars of Denosumab. Vevzuo addresses skeletal events in adults with advanced malignancies. Evfraxy treats o
Announcement as on 07 July 2025

Biocon biologics receives European Commission approval for Vevzuo, Evfraxy Denosumab biosimilars for bone diseases
Biocon Ltd's arm, Biocon Biologics Ltd, has received European Commission authorisation for its Vevzuo and Evfraxy biosimilars, used to treat various bone diseases. Vevzuo addresses bone complications in cancer patients and giant cell tumors, while Evfraxy
Announcement as on 03 July 2025

Karnataka CM's remarks on covid vaccines 'factually incorrect,' says Biocon chief Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw refuted Karnataka CM Siddaramaiah's claim. Siddaramaiah linked covid-19 vaccines to heart attack deaths in Hassan. Shaw stated the vaccines followed rigorous safety protocols. She said the vaccines saved lives. The Union Health Ministry
Announcement as on 03 July 2025

Biocon eyes Canadian bonanza from generics of weight-loss 'super-drugs' Ozempic and Wegovy
Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key markets like Canada, where patents expire next year. Managing Director Siddharth Mittal sees Canada as a prime opportunity, aiming for
Announcement as on 02 July 2025

Biocon drops plan to launch weight-loss drugs in China, executive says
Biocon has scrapped its plans to introduce generic versions of Novo Nordisk's Ozempic and Wegovy in China, citing intense local competition. The decision comes as numerous Chinese drugmakers are developing generics and biosimilars ahead of the semaglutide
Announcement as on 27 June 2025

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 382.2
  • 12Day Average: 390.22
  • 20Day Average: 398.71
  • 50Day Average: 416.07
  • 100Day Average: 412.74
  • 150Day Average: 399.27
  • 200Day Average: 395.22

532523 Indicators & signals

Indicator MACD (12,26,9)

389.87, 399.81, -8.5
Indicator MACD is in negative zone

Indicator ADX (14)

32.38, 15.59, 30.52
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
18 Fri Sep 2026 385.00 379.50 to 388.80 1.32% 0.05 times
17 Thu Sep 2026 380.00 370.45 to 381.75 1.59% 0.03 times
16 Wed Sep 2026 374.05 374.00 to 383.70 -1.82% 0.04 times
15 Tue Sep 2026 381.00 381.00 to 392.50 -2.55% 0.06 times
11 Fri Sep 2026 390.95 384.80 to 396.65 0.24% 0.05 times
10 Thu Sep 2026 390.00 388.65 to 397.50 -1.27% 0.06 times
09 Wed Sep 2026 395.00 393.10 to 403.95 0.62% 9.45 times
08 Tue Sep 2026 392.55 390.90 to 399.50 -0.24% 0.07 times
07 Mon Sep 2026 393.50 388.70 to 397.25 -0.94% 0.16 times
04 Fri Sep 2026 397.25 396.50 to 404.80 -1.18% 0.04 times
03 Thu Sep 2026 402.00 400.60 to 405.70 0.17% 0.03 times
02 Wed Sep 2026 401.30 397.85 to 402.00 0.01% 0.28 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top